What is KPV?
KPV is a naturally occurring tripeptide (Lys-Pro-Val) that represents the C-terminal active fragment of alpha-Melanocyte Stimulating Hormone (α-MSH). It is a tiny, highly stable molecule known for its powerful anti-inflammatory and antimicrobial properties. Because of its small size, it is easily absorbed through the skin and intestinal membranes.
How does KPV work?
KPV exerts its anti-inflammatory effects by entering cells and interacting directly with importin molecules, which prevents the translocation of NF-kB (a major pro-inflammatory transcription factor) into the cell nucleus. By shutting down the NF-kB pathway, KPV inhibits the production of inflammatory cytokines (such as IL-1, IL-6, and TNF-alpha). It also possesses direct antimicrobial properties, particularly against pathogens like Candida albicans.
Primary Documented Uses
- Reducing gut inflammation and treating symptoms of IBD/IBS
- Alleviating inflammatory skin conditions like eczema, psoriasis, and acne
- Accelerating wound healing and reducing scar formation
- Combating systemic and localized inflammatory flare-ups
Research Summary
Research in animal models of Inflammatory Bowel Disease (IBD) shows that oral or systemic administration of KPV dramatically reduces intestinal inflammation, accelerates mucosal healing, and prevents weight loss. In dermatological studies, topical KPV has been shown to reduce skin inflammation in models of psoriasis and eczema, demonstrating efficacy comparable to hydrocortisone but without steroid-induced skin thinning.
Legal and Regulatory Status
KPV is not FDA-approved for human clinical use. It is legally sold as a research chemical for laboratory use. Some cosmetic manufacturers include KPV in topical formulations, though medical claims are restricted.
Frequently Asked Questions
What is KPV?
KPV is A highly potent anti-inflammatory tripeptide derived from alpha-MSH, widely studied for inflammatory bowel disease and skin conditions.
How does KPV work?
KPV exerts its anti-inflammatory effects by entering cells and interacting directly with importin molecules, which prevents the translocation of NF-kB (a major pro-inflammatory transcription factor) into the cell nucleus. By shutting down the NF-kB pathway, KPV inhibits the production of inflammatory cytokines (such as IL-1, IL-6, and TNF-alpha). It also possesses direct antimicrobial properties, particularly against pathogens like Candida albicans.
What does research say about KPV?
Research in animal models of Inflammatory Bowel Disease (IBD) shows that oral or systemic administration of KPV dramatically reduces intestinal inflammation, accelerates mucosal healing, and prevents weight loss. In dermatological studies, topical KPV has been shown to reduce skin inflammation in models of psoriasis and eczema, demonstrating efficacy comparable to hydrocortisone but without steroid-induced skin thinning.
Is KPV FDA-approved or legally available?
KPV is not FDA-approved for human clinical use. It is legally sold as a research chemical for laboratory use. Some cosmetic manufacturers include KPV in topical formulations, though medical claims are restricted.